Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Multiple Sclerosis

  Free Subscription


2 Ann Neurol
1 BMC Neurol
1 Hum Immunol
1 Int J Neurosci
1 J Neuroimmunol
7 J Neurol
2 J Neurol Neurosurg Psychiatry
1 Mult Scler
1 Neurologia (Engl Ed)
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. CALABRESE M, Preziosa P, Scalfari A, Colato E, et al
    Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
    Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26913.
    PubMed         Abstract available

  2. NEIDHART S, Vlad B, Hilty M, Hogelin KA, et al
    HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis.
    Ann Neurol. 2024 Mar 29. doi: 10.1002/ana.26921.
    PubMed         Abstract available

    BMC Neurol

  3. CARDENAS-ROBLEDO S, Arenas-Vargas LE, Arenas RD, Gaspar-Toro JM, et al
    Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors.
    BMC Neurol. 2024;24:108.
    PubMed         Abstract available

    Hum Immunol

  4. BOULLERNE AI, Goudey B, Paganini J, Erlichster M, et al
    Validation of tag SNPs for multiple sclerosis HLA risk alleles across the 1000 genomes panel.
    Hum Immunol. 2024 Apr 3:110790. doi: 10.1016/j.humimm.2024.110790.
    PubMed         Abstract available

    Int J Neurosci

  5. GHARIGHNIA S, Omidi A, Ragerdi Kashani I, Sepand MR, et al
    Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model.
    Int J Neurosci. 2024;134:409-419.
    PubMed         Abstract available

    J Neuroimmunol

  6. SRIWASTAVA S, Elkhooly M, Amatya S, Shrestha K, et al
    Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis.
    J Neuroimmunol. 2024;390:578315.
    PubMed         Abstract available

    J Neurol

  7. HUA T, Fan H, Duan Y, Tian D, et al
    Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12281.
    PubMed         Abstract available

  8. GLASER A, Butzkueven H, van der Walt A, Gray O, et al
    Big Multiple Sclerosis Data network: an international registry research network.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12303.
    PubMed         Abstract available

  9. GUERRIERI S, Rubin M, Gattuso I, Zanetta C, et al
    Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.
    J Neurol. 2024 Apr 2. doi: 10.1007/s00415-024-12342.

  10. SIGNORIELLO E, Foschi M, Lanzillo R, Frau J, et al
    Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12291.
    PubMed         Abstract available

  11. MAIDA E, Moccia M, Palladino R, Borriello G, et al
    ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328.
    PubMed         Abstract available

  12. STEFANOU MI, Giannopapas V, Kitsos DK, Chondrogianni M, et al
    Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12331.
    PubMed         Abstract available

  13. CELIK M, Baba C, Irmak C, Ozakbas S, et al
    Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12333.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  14. MAHLER MR, Magyari M, Pontieri L, Elberling F, et al
    Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
    J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2023-333265.
    PubMed         Abstract available

  15. DEKEYSER C, Hautekeete M, Cambron M, Van Pesch V, et al
    Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
    J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2023-333307.
    PubMed         Abstract available

    Mult Scler

  16. KWON S, Han KD, Jung JH, Cho EB, et al
    Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea.
    Mult Scler. 2024 Apr 1:13524585241237093. doi: 10.1177/13524585241237093.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  17. RAMOS-GONZALEZ EJ, Bitzer-Quintero OK, Ortiz G, Hernandez-Cruz JJ, et al
    Relationship between inflammation and oxidative stress and its effect on multiple sclerosis.
    Neurologia (Engl Ed). 2024;39:292-301.
    PubMed         Abstract available

    PLoS One

  18. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    PubMed         Abstract available

  19. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.